MediWound Ltd. (NASDAQ:MDWD) is up 6% in a week. On Tuesday, the company announced encouraging topline data from the pivotal third phase pediatric clinical study, Children Innovation Debridement Study (CIDS) NexoBrid, in treating children with severe burns. The study evaluated the safety and efficacy of NexoBrid relative to the currently available standard-of-care treatments. CIDS met …
Continue reading “MediWound Ltd. (NASDAQ:MDWD) Stock Jumps 6% in a Week: More to Come?”